Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes
- 1 March 2015
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 43 (3) , 335-343
Abstract
Bacterial sepsis is characterized by a rapid increase in the expression of inflammatory mediators to initiate the acute phase response in liver. Inflammatory mediator release is counterbalanced by the coordinated expression of anti-inflammatory molecules such as interleukin 1 receptor antagonist (IL1-Ra) through time. This study determined whether activation of pregnane X receptor (PXR, NR1I2) alters the lipopolysaccharide (LPS)-inducible gene expression program in primary cultures of hepatocytes (PCHs). Preactivation of PXR for 24 hours in PCHs isolated from wild-type mice suppressed the subsequent LPS-inducible expression of the key inflammatory mediators interleukin 1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α (TNFα) but not in PCHs isolated from Pxr-null (PXR-knockout [KO]) mice. Basal expression of key inflammatory cytokines was elevated in PCHs from PXR-KO mice. Stimulation of PCHs from PXR-KO mice with LPS alone produced enhanced levels of IL-1β when compared with wild-type mice. Experiments performed using PCHs from both humanized-PXR transgenic mice as well as human donors indicate that prolonged activation of PXR produces an increased secretion of IL1-Ra from cells through time. Our data reveal a working model that describes a pivotal role for PXR in both inhibiting as well as in resolving the inflammatory response in hepatocytes. Understanding the molecular details of how PXR is converted from a positive regulator of drug-metabolizing enzymes into a transcriptional suppressor of inflammation in liver will provide new pharmacologic strategies for modulating inflammatory-related diseases in the liver and intestine.Keywords
This publication has 56 references indexed in Scilit:
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanismsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Pregnane X Receptor Is SUMOylated to Repress the Inflammatory ResponseThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expressionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Something about SUMO inhibits transcriptionCurrent Opinion in Genetics & Development, 2005
- Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytesCancer Chemotherapy and Pharmacology, 2004
- Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-HydroxytamoxifenDrug Metabolism and Disposition, 2002
- Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase responseBiochemical and Biophysical Research Communications, 2002
- Physiologic role of interleukin-1 receptor antagonistArthritis Research & Therapy, 2000
- Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanismCell, 1986